{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:59:22Z","timestamp":1791172762312,"version":"4.1.0"},"reference-count":55,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2014,12,18]]},"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The recent availability of novel antiviral drugs has raised new hope for a more effective treatment of hepatitis C virus (HCV) infection and its severe sequelae. However, in the case of non-responding or relapsing patients, alternative strategies are needed. To this end we have used chimeric antigen receptors (CARs), a very promising approach recently used in several clinical trials to redirect primary human T cells against different tumours. In particular, we designed the first CARs against HCV targeting the HCV\/E2 glycoprotein (HCV\/E2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Anti-HCV\/E2 CARs were composed of single-chain variable fragments (scFvs) obtained from a broadly cross-reactive and cross-neutralising human monoclonal antibody (mAb), e137, fused to the intracellular signalling motif of the costimulatory CD28 molecule and the CD3\u03b6 domain. Activity of CAR-grafted T cells was evaluated in vitro against HCV\/E2-transfected cells as well as hepatocytes infected with cell culture-derived HCV (HCVcc).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this proof-of-concept study, retrovirus-transduced human T cells expressing anti-HCV\/E2 CARs were endowed with specific antigen recognition accompanied by degranulation and secretion of proinflammatory and antiviral cytokines, such as interferon \u03b3, interleukin 2 and tumour necrosis factor \u03b1. Moreover, CAR-grafted T cells were capable of lysing target cells of both hepatic and non-hepatic origin expressing on their surface the HCV\/E2 glycoproteins of the most clinically relevant genotypes, including 1a, 1b, 2a, 3a, 4 and 5. Finally, and more importantly, they were capable of lysing HCVcc-infected hepatocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Clearance of HCV-infected cells is a major therapeutic goal in chronic HCV infection, and adoptive transfer of anti-HCV\/E2 CARs-grafted T cells represents a promising new therapeutic tool.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2014-308316","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T23:56:05Z","timestamp":1423266965000},"page":"512-523","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":88,"title":["Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein"],"prefix":"10.1136","volume":"65","author":[{"given":"Giuseppe A","family":"Sautto","sequence":"first","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Wisskirchen","sequence":"additional","affiliation":[{"name":"Institute of Virology, Technische Universit\u00e4t M\u00fcnchen\/Helmholtz Zentrum M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Clementi","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Castelli","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta A","family":"Diotti","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Graf","sequence":"additional","affiliation":[{"name":"Institute of Virology, Technische Universit\u00e4t M\u00fcnchen\/Helmholtz Zentrum M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Clementi","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Burioni","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[{"name":"Institute of Virology, Technische Universit\u00e4t M\u00fcnchen\/Helmholtz Zentrum M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicasio","family":"Mancini","sequence":"additional","affiliation":[{"name":"Laboratorio di Microbiologia e Virologia, Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,2,6]]},"reference":[{"key":"2025121221301252000_65.3.512.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03432.x"},{"key":"2025121221301252000_65.3.512.2","doi-asserted-by":"crossref","first-page":"705013","DOI":"10.1155\/2012\/705013","article-title":"HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role","volume":"2012","author":"Sautto","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"2025121221301252000_65.3.512.3","doi-asserted-by":"publisher","DOI":"10.3390\/v4112924"},{"key":"2025121221301252000_65.3.512.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2008.03.008"},{"key":"2025121221301252000_65.3.512.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2014.02.002"},{"key":"2025121221301252000_65.3.512.6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/1871526514666140321104049","article-title":"Mechanisms of anti-retroviral drug resistance: implications for novel drug discovery and development","volume":"13","author":"Emamzadeh-Fard","year":"2013","journal-title":"Infect Disord Drug Targets"},{"key":"2025121221301252000_65.3.512.7","doi-asserted-by":"publisher","DOI":"10.2174\/187152612804142251"},{"key":"2025121221301252000_65.3.512.8","doi-asserted-by":"crossref","first-page":"521231","DOI":"10.1155\/2013\/521231","article-title":"Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T cell-activating peptides","volume":"2013","author":"Castelli","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2025121221301252000_65.3.512.9","doi-asserted-by":"crossref","first-page":"890517","DOI":"10.1155\/2013\/890517","article-title":"New insights in recurrent HCV infection after liver transplantation","volume":"2013","author":"Hsu","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2025121221301252000_65.3.512.10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/450963"},{"key":"2025121221301252000_65.3.512.11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i17.2406"},{"key":"2025121221301252000_65.3.512.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(03)00635-5"},{"key":"2025121221301252000_65.3.512.13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26430"},{"key":"2025121221301252000_65.3.512.14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01592-10"},{"key":"2025121221301252000_65.3.512.15","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27340-7_10"},{"key":"2025121221301252000_65.3.512.16","doi-asserted-by":"publisher","DOI":"10.3390\/v4010001"},{"key":"2025121221301252000_65.3.512.17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0607026104"},{"key":"2025121221301252000_65.3.512.18","first-page":"125","article-title":"Humoral immune response against hepatitis C virus","volume":"17","author":"Burioni","year":"2003","journal-title":"J Biol Regul Homeost Agents"},{"key":"2025121221301252000_65.3.512.19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01986-07"},{"key":"2025121221301252000_65.3.512.20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008254"},{"key":"2025121221301252000_65.3.512.21","first-page":"475","article-title":"Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein","volume":"35","author":"Diotti","year":"2012","journal-title":"New Microbiol"},{"key":"2025121221301252000_65.3.512.22","first-page":"387","article-title":"New therapeutic options for HCV infection in the monoclonal antibody era","volume":"35","author":"Sautto","year":"2012","journal-title":"New Microbiol"},{"key":"2025121221301252000_65.3.512.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.05.008"},{"key":"2025121221301252000_65.3.512.24","first-page":"183","article-title":"Heterogeneity of the humoral anti-HCV\/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV\/E2 human monoclonal antibodies","volume":"17","author":"Mancini","year":"2003","journal-title":"J Biol Regul Homeost Agents"},{"key":"2025121221301252000_65.3.512.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.07.013"},{"key":"2025121221301252000_65.3.512.26","doi-asserted-by":"publisher","DOI":"10.3390\/v4091731"},{"key":"2025121221301252000_65.3.512.27","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.1014"},{"key":"2025121221301252000_65.3.512.28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.22.11775-11779.2002"},{"key":"2025121221301252000_65.3.512.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.06.042"},{"key":"2025121221301252000_65.3.512.30","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20704"},{"key":"2025121221301252000_65.3.512.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004128"},{"key":"2025121221301252000_65.3.512.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001018"},{"key":"2025121221301252000_65.3.512.33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fimmu.2013.00371","article-title":"Antigen-specific T cell activation independently of the MHC: chimeric antigen receptor-redirected T cells","volume":"4","author":"Chmielewski","year":"2013","journal-title":"Front Immunol"},{"key":"2025121221301252000_65.3.512.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.08.011"},{"key":"2025121221301252000_65.3.512.35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.20.9986-9990.2001"},{"key":"2025121221301252000_65.3.512.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(97)89904-9"},{"key":"2025121221301252000_65.3.512.37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510280331"},{"key":"2025121221301252000_65.3.512.38","first-page":"289","article-title":"A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments","volume":"35","author":"Solforosi","year":"2012","journal-title":"New Microbiol"},{"key":"2025121221301252000_65.3.512.39","doi-asserted-by":"publisher","DOI":"10.1089\/104303403322167993"},{"key":"2025121221301252000_65.3.512.40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.04.047"},{"key":"2025121221301252000_65.3.512.41","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00271-06"},{"key":"2025121221301252000_65.3.512.42","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0022-2275(20)37139-X","article-title":"Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2","volume":"38","author":"Tam","year":"1997","journal-title":"J Lipid Res"},{"key":"2025121221301252000_65.3.512.43","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00246-09"},{"key":"2025121221301252000_65.3.512.44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061338"},{"key":"2025121221301252000_65.3.512.45","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.210"},{"key":"2025121221301252000_65.3.512.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012154"},{"key":"2025121221301252000_65.3.512.47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021756"},{"key":"2025121221301252000_65.3.512.48","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.107"},{"key":"2025121221301252000_65.3.512.49","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302413"},{"key":"2025121221301252000_65.3.512.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103849"},{"key":"2025121221301252000_65.3.512.51","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.11.002"},{"key":"2025121221301252000_65.3.512.52","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27340-7_3"},{"key":"2025121221301252000_65.3.512.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.07.013"},{"key":"2025121221301252000_65.3.512.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.09.008"},{"key":"2025121221301252000_65.3.512.55","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.01.001"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2014-308316","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:30:19Z","timestamp":1765603819000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2014-308316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,6]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,2,12]]},"published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1136\/gutjnl-2014-308316"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2014-308316","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,6]]}}}